SCHEMBL8124164

SCHEMBL8124164

CC(C)c1ccccc1C(=N)Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 3/20 0.48
GABRB2 P47870 2/20 0.48
GABRG2 P18507 2/20 0.44
GABRB3 P28472 2/20 0.44
LMNA P02545 2/20 0.44
FAAH O00519 2/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
HPGD P15428 1/20 0.44
TSHR P16473 1/20 0.44
GABRB1 P18505 1/20 0.44
PTGS1 P23219 1/20 0.44
SLC6A2 P23975 1/20 0.44
HTR2C P28335 1/20 0.44
GABRA5 P31644 1/20 0.44
GABRA3 P34903 1/20 0.44
HTR2B P41595 1/20 0.44
GABRA2 P47869 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6063471 0.83 GABRA1 (0.39) GABRA1GABRB2GABRG2GABRB3LMNA
SCHEMBL2153533 0.82 ALDH1A1 (0.50) GABRA1GABRB2GABRG2GABRB3LMNA
SCHEMBL20057673 0.79 GABRA1 (0.50) GABRA1GABRB2GABRG2GABRB3LMNA
SCHEMBL15543688 0.77 GABRA1 (0.48) GABRA1GABRB2GABRG2GABRB3LMNA
SCHEMBL8837659 0.77 GABRA1 (0.48) GABRA1GABRB2GABRG2GABRB3LMNA
SCHEMBL4056882 0.77 GABRA1 (0.48) GABRA1GABRB2GABRG2GABRB3LMNA
SCHEMBL9126701 0.77 ALDH1A1 (0.40) LMNACA1CA2CYP3A4HPGD
SCHEMBL9864537 0.76 GABRA1 (0.52) GABRA1GABRB2GABRG2GABRB3LMNA
SCHEMBL1148330 0.76 GABRA1 (0.52) GABRA1GABRB2GABRG2GABRB3LMNA
SCHEMBL1635308 0.74 GABRA1 (0.50) GABRA1GABRB2GABRG2GABRB3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3999183-A1 COMPOUND HAVING KDM5 INHIBITORY ACTIVITY AND PHARMACEUTICAL USE THEREOF Ono Pharmaceutical Co., Ltd. (JP) 2022-05-25 EP disclosed
WO-2021010492-A1 COMPOUND HAVING KDM5 INHIBITORY ACTIVITY AND PHARMACEUTICAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2021-01-21 WO disclosed
EP-1049691-A1 SUBSTITUTED 5-(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL) CYCLOPENTENOPYRIDINE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2000-11-08 EP disclosed
WO-1999037639-A1 SUBSTITUTED 5-(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL) CYCLOPENTENOPYRIDINE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 1999-07-29 WO disclosed